PandemieGrippaleV1, PascalFrancis, Corpus, bibRecord, 000188

Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic

Identifieur interne : 000188 ( PascalFrancis/Corpus ); précédent : 000187; suivant : 000189

Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic

Auteurs : Claudia Vellozzi ; Shahed Iqbal ; Brock Stewart ; Jerome Tokars ; Frank Destefano

Source :

American journal of public health : (1971) [ 0090-0036 ] ; 2014.

RBID : Francis:14-0118472

Descripteurs français

Pascal (Inist)
- Polyradiculonévrite de Guillain-Barré, Facteur risque, Risque, Population, 2009, Santé publique, Grippe pandémique, Grippe H1N1.

English descriptors

KwdEn :
- 2009, Guillain-Barré syndrome, H1N1 influenza, Population, Public health, Risk, Risk factor.

Abstract

Objectives. We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0090-0036`
A02	`01`			`@0 AJPEAG`
A03		`1`		`@0 Am. j. publ. health : (1971)`
A05				`@2 104`
A06				`@2 4`
A08	`01`	`1`	`ENG`	`@1 Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic`
A11	`01`	`1`		`@1 VELLOZZI (Claudia)`
A11	`02`	`1`		`@1 IQBAL (Shahed)`
A11	`03`	`1`		`@1 STEWART (Brock)`
A11	`04`	`1`		`@1 TOKARS (Jerome)`
A11	`05`	`1`		`@1 DESTEFANO (Frank)`
A14	`01`			`@1 Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention @2 Atlanta, GA @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 5 aut.`
A14	`02`			`@1 Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention @3 USA @Z 4 aut.`
A20				`@1 696-701`
A21				`@1 2014`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 2009 @5 354000503204650180`
A44				`@0 0000 @1 © 2014 INIST-CNRS. All rights reserved.`
A45				`@0 38 ref.`
A47	`01`	`1`		`@0 14-0118472`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 American journal of public health : (1971)`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Objectives. We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.
C02	`01`	`X`		`@0 760L @1 XI`
C02	`02`	`X`		`@0 760A @1 I`
C03	`01`	`X`	`FRE`	`@0 Polyradiculonévrite de Guillain-Barré @5 01`
C03	`01`	`X`	`ENG`	`@0 Guillain-Barré syndrome @5 01`
C03	`01`	`X`	`SPA`	`@0 Polirradiculoneuritis Guillain-Barré @5 01`
C03	`02`	`X`	`FRE`	`@0 Facteur risque @5 09`
C03	`02`	`X`	`ENG`	`@0 Risk factor @5 09`
C03	`02`	`X`	`SPA`	`@0 Factor riesgo @5 09`
C03	`03`	`X`	`FRE`	`@0 Risque @5 10`
C03	`03`	`X`	`ENG`	`@0 Risk @5 10`
C03	`03`	`X`	`SPA`	`@0 Riesgo @5 10`
C03	`04`	`X`	`FRE`	`@0 Population @5 11`
C03	`04`	`X`	`ENG`	`@0 Population @5 11`
C03	`04`	`X`	`SPA`	`@0 Población @5 11`
C03	`05`	`X`	`FRE`	`@0 2009 @5 12`
C03	`05`	`X`	`ENG`	`@0 2009 @5 12`
C03	`05`	`X`	`SPA`	`@0 2009 @5 12`
C03	`06`	`X`	`FRE`	`@0 Santé publique @5 13`
C03	`06`	`X`	`ENG`	`@0 Public health @5 13`
C03	`06`	`X`	`SPA`	`@0 Salud pública @5 13`
C03	`07`	`X`	`FRE`	`@0 Grippe pandémique @4 INC @5 86`
C03	`08`	`X`	`FRE`	`@0 Grippe H1N1 @4 CD @5 96`
C03	`08`	`X`	`ENG`	`@0 H1N1 influenza @4 CD @5 96`
C03	`08`	`X`	`SPA`	`@0 Gripe H1N1 @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Maladie inflammatoire @5 37`
C07	`01`	`X`	`ENG`	`@0 Inflammatory disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Enfermedad inflamatoria @5 37`
C07	`02`	`X`	`FRE`	`@0 Pathologie du système nerveux périphérique @5 38`
C07	`02`	`X`	`ENG`	`@0 Peripheral nerve disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Nervio periférico patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 39`
C07	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 39`
C07	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Pathologie de l'appareil respiratoire @5 40`
C07	`04`	`X`	`ENG`	`@0 Respiratory disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Aparato respiratorio patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Virose @5 41`
C07	`05`	`X`	`ENG`	`@0 Viral disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Virosis @5 41`
C07	`06`	`X`	`FRE`	`@0 Infection`
C07	`06`	`X`	`ENG`	`@0 Infection`
C07	`06`	`X`	`SPA`	`@0 Infección`
N21				`@1 153`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	FRANCIS 14-0118472 INIST
ET :	Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic
AU :	VELLOZZI (Claudia); IQBAL (Shahed); STEWART (Brock); TOKARS (Jerome); DESTEFANO (Frank)
AF :	Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention/Atlanta, GA/Etats-Unis (1 aut., 2 aut., 3 aut., 5 aut.); Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention/Etats-Unis (4 aut.)
DT :	Publication en série; Niveau analytique
SO :	American journal of public health : (1971); ISSN 0090-0036; Coden AJPEAG; Etats-Unis; Da. 2014; Vol. 104; No. 4; Pp. 696-701; Bibl. 38 ref.
LA :	Anglais
EA :	Objectives. We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.
CC :	760L; 760A
FD :	Polyradiculonévrite de Guillain-Barré; Facteur risque; Risque; Population; 2009; Santé publique; Grippe pandémique; Grippe H1N1
FG :	Maladie inflammatoire; Pathologie du système nerveux périphérique; Pathologie du système nerveux; Pathologie de l'appareil respiratoire; Virose; Infection
ED :	Guillain-Barré syndrome; Risk factor; Risk; Population; 2009; Public health; H1N1 influenza
EG :	Inflammatory disease; Peripheral nerve disease; Nervous system diseases; Respiratory disease; Viral disease; Infection
SD :	Polirradiculoneuritis Guillain-Barré; Factor riesgo; Riesgo; Población; 2009; Salud pública; Gripe H1N1
LO :	INIST-2009.354000503204650180
ID :	14-0118472

Links to Exploration step

Francis:14-0118472

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic</title>
<author><name sortKey="Vellozzi, Claudia" sort="Vellozzi, Claudia" uniqKey="Vellozzi C" first="Claudia" last="Vellozzi">Claudia Vellozzi</name>
<affiliation><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Iqbal, Shahed" sort="Iqbal, Shahed" uniqKey="Iqbal S" first="Shahed" last="Iqbal">Shahed Iqbal</name>
<affiliation><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stewart, Brock" sort="Stewart, Brock" uniqKey="Stewart B" first="Brock" last="Stewart">Brock Stewart</name>
<affiliation><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tokars, Jerome" sort="Tokars, Jerome" uniqKey="Tokars J" first="Jerome" last="Tokars">Jerome Tokars</name>
<affiliation><inist:fA14 i1="02"><s1>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</s1>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Destefano, Frank" sort="Destefano, Frank" uniqKey="Destefano F" first="Frank" last="Destefano">Frank Destefano</name>
<affiliation><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0118472</idno>
<date when="2014">2014</date>
<idno type="stanalyst">FRANCIS 14-0118472 INIST</idno>
<idno type="RBID">Francis:14-0118472</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000188</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic</title>
<author><name sortKey="Vellozzi, Claudia" sort="Vellozzi, Claudia" uniqKey="Vellozzi C" first="Claudia" last="Vellozzi">Claudia Vellozzi</name>
<affiliation><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Iqbal, Shahed" sort="Iqbal, Shahed" uniqKey="Iqbal S" first="Shahed" last="Iqbal">Shahed Iqbal</name>
<affiliation><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stewart, Brock" sort="Stewart, Brock" uniqKey="Stewart B" first="Brock" last="Stewart">Brock Stewart</name>
<affiliation><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tokars, Jerome" sort="Tokars, Jerome" uniqKey="Tokars J" first="Jerome" last="Tokars">Jerome Tokars</name>
<affiliation><inist:fA14 i1="02"><s1>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</s1>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Destefano, Frank" sort="Destefano, Frank" uniqKey="Destefano F" first="Frank" last="Destefano">Frank Destefano</name>
<affiliation><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">American journal of public health : (1971)</title>
<title level="j" type="abbreviated">Am. j. publ. health : (1971)</title>
<idno type="ISSN">0090-0036</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">American journal of public health : (1971)</title>
<title level="j" type="abbreviated">Am. j. publ. health : (1971)</title>
<idno type="ISSN">0090-0036</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>2009</term>
<term>Guillain-Barré syndrome</term>
<term>H1N1 influenza</term>
<term>Population</term>
<term>Public health</term>
<term>Risk</term>
<term>Risk factor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Polyradiculonévrite de Guillain-Barré</term>
<term>Facteur risque</term>
<term>Risque</term>
<term>Population</term>
<term>2009</term>
<term>Santé publique</term>
<term>Grippe pandémique</term>
<term>Grippe H1N1</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objectives. We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0090-0036</s0>
</fA01>
<fA02 i1="01"><s0>AJPEAG</s0>
</fA02>
<fA03 i2="1"><s0>Am. j. publ. health : (1971)</s0>
</fA03>
<fA05><s2>104</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>VELLOZZI (Claudia)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>IQBAL (Shahed)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>STEWART (Brock)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>TOKARS (Jerome)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>DESTEFANO (Frank)</s1>
</fA11>
<fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</s1>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>696-701</s1>
</fA20>
<fA21><s1>2014</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>2009</s2>
<s5>354000503204650180</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2014 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>14-0118472</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>American journal of public health : (1971)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Objectives. We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>760L</s0>
<s1>XI</s1>
</fC02>
<fC02 i1="02" i2="X"><s0>760A</s0>
<s1>I</s1>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Polyradiculonévrite de Guillain-Barré</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Guillain-Barré syndrome</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Polirradiculoneuritis Guillain-Barré</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Risque</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Risk</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Riesgo</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Population</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Population</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Población</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>2009</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>2009</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>2009</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Public health</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Grippe pandémique</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Grippe H1N1</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>H1N1 influenza</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Gripe H1N1</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Maladie inflammatoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Inflammatory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Enfermedad inflamatoria</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie du système nerveux périphérique</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Peripheral nerve disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Nervio periférico patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie de l'appareil respiratoire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Virose</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Viral disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Virosis</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fN21><s1>153</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>FRANCIS 14-0118472 INIST</NO>
<ET>Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic</ET>
<AU>VELLOZZI (Claudia); IQBAL (Shahed); STEWART (Brock); TOKARS (Jerome); DESTEFANO (Frank)</AU>
<AF>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention/Atlanta, GA/Etats-Unis (1 aut., 2 aut., 3 aut., 5 aut.); Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention/Etats-Unis (4 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>American journal of public health : (1971); ISSN 0090-0036; Coden AJPEAG; Etats-Unis; Da. 2014; Vol. 104; No. 4; Pp. 696-701; Bibl. 38 ref.</SO>
<LA>Anglais</LA>
<EA>Objectives. We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.</EA>
<CC>760L; 760A</CC>
<FD>Polyradiculonévrite de Guillain-Barré; Facteur risque; Risque; Population; 2009; Santé publique; Grippe pandémique; Grippe H1N1</FD>
<FG>Maladie inflammatoire; Pathologie du système nerveux périphérique; Pathologie du   système nerveux; Pathologie de l'appareil respiratoire; Virose; Infection</FG>
<ED>Guillain-Barré syndrome; Risk factor; Risk; Population; 2009; Public health; H1N1 influenza</ED>
<EG>Inflammatory disease; Peripheral nerve disease; Nervous system diseases; Respiratory disease; Viral disease; Infection</EG>
<SD>Polirradiculoneuritis Guillain-Barré; Factor riesgo; Riesgo; Población; 2009; Salud pública; Gripe H1N1</SD>
<LO>INIST-2009.354000503204650180</LO>
<ID>14-0118472</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000188 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000188 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Francis:14-0118472
   |texte=   Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic
}}

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic

Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri